Huntercad470

The Global Jet Lag Therapy Market was valued at USD 392.0 Million in 2019 and is forecasted to reach USD 548.5 Million by 2027 at a CAGR of 4.3%. The jet lag therapy products across the globe are mainly used to cope up with the jet lag symptoms, which primarily includes, sleepiness, insomnia, daytime fatigue, constipation, diarrhea, dehydration, lack of concentration and nausea, among others. The market comprises of a spectrum of potent technologies such as, portable light therapy products, different types of drugs, wearable light therapy devices and herbal products.

The favorable factors that are likely to drive prospective growth of the market are mainly inception of safe and effective wearable devices, increase in compliance of wearable devices among end-users, minimum complications or negative effects, and rise in the number of travelers per year globally. In spite of the cut throat competition in the jet lag therapy market across European and North American regions, the future market growth is particularly expected in China, Japan, India, Mexico, and Brazil as well as other emerging economies where the market penetration of jet lag therapy is significantly low when compared to that of the developed economies.

Over the years, jet lag has been a common and dominant problem among long distance flyers but still, there is still no definition of this disorder which has been set as standard. Majority of the studies include symptoms of weakness, decreased daytime alertness, fatigue, difficulty in concentrating, memory problems, daytime sleepiness, and lack of energy after a long flight. Jet lag disorder is generally temporary and usually does not need medication and treatment, which often acts as a market restraint. There are cases when the symptoms last longer and that is when the offerings of the market come into play. Therefore, if an air traveler is consistently affected by jet lag, then necessary medications, or light therapy to improve the condition may as well be prescribed by a doctor, which hence stimulates market growth.

Product Insights:

The Prescription Drugs segment, had a market share of 36.8% in 2019

Windows Driver Package - Valkee NPT-1000 USB Driver (. Valkee - Shareware. Update for CCleaner is available for download. Evernote update available. NVIDIA driver updates close security vulnerabilities. Update for Photoshop and Illustrator available. GOOGLE CHROME: The browser will start downloading My Valkee software installer (Valkee- 1.0.0.exe). Press CTRL+J when the download is complete. This will open Downloads tab. Double click Valkee-1.0.0.exe to start the installer.

Although the prescription drugs held the majority of the market share in 2019, yet the melatonin segment of the jet lag therapy market has been gaining traction over the years and is anticipated to grow at a CAGR of 4.7% throughout the forecasted period. This can be attributed to the fact that melatonin supplements help the human body in adjusting to the jet lag by managing the circadian rhythms. It has been found through various reliable sources that a dosage as low as 0.5 mg is just as effective as higher doses. The MHRA has approved the licensing of two melatonin products namely melatonin 1mg/ml oral solution and melatonin 3mg film-coated tablets for the short-term treatment of jet-lag in adults. Prior to this, the utilization of melatonin for the treatment of jet-lag was off license and it was only licensed for the treatment of insomnia on a short term basis. This is likely to boost the segment’s growth over the coming years.

Prescription drugs often tend to include hypnotic sleeping pill to help an individual get rest at the proper times when they reach the destination in order to help avoid sleep deprivation during the flight. However, with advancements in technology, medical devices segment is also penetrating the market. It had a market valuation of USD 53.8 million in 2019 because these devices assist in regulating several physiological processes, including sleep, hormone secretion, metabolism and even how the brain function.

The Business Travelers segment was valued at USD 126.2 Million in 2019

The business travelers segment held the majority share of the market in 2019 and is likely to continue its dominance over the forecast period due to high traveling frequencies of business executives from one region to another.

Various problems related to jetlag is also creeping in among cabin crew and treatment of this particular segment is not simple. The cabin crew segment is likely to grow at a CAGR of 4.3% throughout the forecasted period. Preserving sleep, staying alert during the flight and the associated performance are the major considerations from the crew’s point of view. Resynchronization of addresses among crew members is very common which affects the circadian response of their bodies. However, change in time zones and its respective circadian response is dependent on individualistic characteristics like tau, initial circadian status and light sensitivity, natural light at destination and thus the season (photoperiod), the individual exposure to artificial and natural light in the aircraft as well as the departure and arrival time of the aircraft.

Seasonal travelers contribute considerably less to the overall market growth as the frequency of jet lag is way less than business executives and cabin crew members. Despite this, the segment contributed a valuation of USD 65.4 million to the market which can be attributed to the growing number of seasonal travelers from one part of the globe to another.

The Over the Counter segment is forecasted to grow at a CAGR of 4.5% throughout the forecasted period

The over the counter segment accounted for the largest market share in 2019 and is likely to do so over the coming years because of the availability of a wide variety of products at various retails outlets and the consistently growing sales figures of jet lag devices and medications in these counters.

Moreover, the online pharmacies segment is expected to register a market valuation of USD 252.3 million by 2027 owing to growing awareness levels about online shopping specially among young travelers and an accelerating number of product approvals which allows various online portals to sell diabetes products with proper guidelines and without any hassles.

North America held the largest market share of around 39.8% in the Jet Lag Therapy market in 2019

In terms of revenue, North America is the most dominant market for jet lag therapy, followed by Asia Pacific. In the North American region, the U.S. holds the majority share of the market. LATAM and MEA are emerging markets, which are expected to witness significant growth during the forecasted span. The prominence of growth in these regions is attributed to growing number of air travellers, increasing growth of health care industries, and rise in the frequency of government investment in order to develop health care infrastructure. In countries such as China, India, and Brazil, the jet lag therapy market is projected to expand manifold over the forecasted years due to rise in awareness levels among the population regarding jet lag and its therapy.

The market for Jet Lag Therapy is highly fragmented with a large number of small as well as medium-sized manufacturers, which account for a major global share of the market. The manufacturers involved in the Jet Lag Therapy market are desegregated across the value chain. Some of the prominent players in the Jet Lag Therapy market include:

• Nature Bright
• Lumie
• Northern Light Technologies
• Re-Timer
• Propeaq
• Royal Philips
• Lucimed
• Valkee
• Vielight Inc.
• Verilux, Inc.

In June 2020, Jet Candy, a 100% natural homeopathic remedy developer based out of Europe launched anti-viral flight kids equipped with homeopathic jet lag remedies. According to Rosalind Milani Gallieni, founder of Jet Candy, this kit will help to curb disorientation, fatigue, dehydration, mental sharpness and other symptoms which are usually associated with the disruption of the circadian rhythms

Scope Of Research

Download Valkee Driver Download

This report forecasts revenue growth at a global, regional and country level and provides an analysis of the market trends in each of the sub-segments from 2018 to 2027. The scope of the report can be defined as:

Emergen Research has segmented the global Jet Lag Therapy Market on the basis of product, distribution channel, end user and region:

• Product Outlook (Revenue, USD Billion; 2017-2027)

  • Prescription Drugs
  • Melatonin
  • Herbal and Natural Products
  • Medical Devices
  • Others

Download Valkee Driverpack

• Distribution Channel Outlook (Revenue, USD Billion; 2017-2027)

  • Over the Counter
  • Online

Download Valkee Drivers

• End User Outlook (Revenue, USD Billion; 2017-2027)

  • Business Travelers
  • Cabin Crew
  • Athletes
  • Seasonal Travelers
  • Others

Download Valkee Driver Printer

• Regional Outlook (Revenue, USD Billion; 2017-2027)

  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. UK
    3. France
    4. BENELUX
    5. Rest of Europe
  • Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • MEA
    1. Saudi Arabia
    2. UAE
    3. Rest of MEA